Accessibility: Skip TopNav
Robert K. Ho
Neoleukin Therapeutics announces appointment of Robert Ho as Chief Financial Officer, effective March 16, 2020.
Format
JPEG
Source
Neoleukin Therapeutics, Inc.
Downloads
Original
Large
Medium
Small